Prevalence of Xerostomia in Healthy Individuals

Authors

  • Sana Shah
  • Madiha Shah
  • Mahrukh Shah
  • Abid Laghari

Keywords:

Drugs, Frequency, Systemic illness, Tobacco consumption, Xerostomia

Abstract

ABSTRACT:
Objective:To determine the prevalence of Xerostomia in apparently healthy individuals.
Methodology:This prospective cross sectional study was conducted on persons accompanying the patients at
Medical and Dental OPD of Muhammad Medical College, Mirpurkhas in collaboration with Liaquat University of
Health Sciences (LUMHS) Jamshoro from January 2016 to July 2016. 156 patients visited and the accompanying
persons were 3015. Only adults were included and 915 patients consented to participate. Standardized questionnaire
regarding demographic details, systemic diseases, use of drugs, and cigarette smoking was filled. Fox questionnaire
was used to confirm Xerostomia. The data collected was analyzed by SPSS version 22. Qualitative variables were
expressed as number and in percentage.
Results: Among nine hundred and fifteen participants, age range was 21-65 years. The mean age was 47±7.6years,
those above 30 years were 813 (88.9%), whereas under 30years were 102 (11.1%). Xerostomia was more common
in persons above 30 years and difference between two age groups was statistically significant. In our study, 317
(34.6%) gave history of tobacco consumption as cigarettes or gutka or pan. Out of 915 patients, 508 (55.5%) had
systemic diseases. Out of these 508 only 387 (76.1%) were taking medications. A significant association of Xerostomia
with drug intake was seen.
Conclusion: The frequency of Xerostomia in apparently healthy subjects was high and alarming. Predisposing
factors were age, female gender, systemic disease, use of drug and tobacco consumption.

References

Fox PC, Eversole LR. Diseases of the salivary glands. In Essentials of Oral Medicine. Eds. Eversole LR, Silver- man, Jr. S, Truelove EL. B.C. Decker Inc. Hamilton, Ontario, Canada. 2001: 260-76

Brown G, Tailer P. Muscuranic Agonist & Antagonist. IN Joel G, Hardman, Lee E, Alfred Goodman Gillman. Goodman & Gillman Pharmacological Basis Of Thera- peutics 10th Ed. Pubication, McGraw Hill. 2001;155 -8

Billings RJ, Proskin HM, Moss ME. Xerostomia and associated factors in a community-dwelling adult population. Community Dent Oral Epidemiol 1996;24(5): 312-6

Ship JA, Fox PC, Baum BJ. How much saliva is enough? ‘Normal’ function defined. J Am Dent Assoc1991;122: 63–9

Joel TJ, Suguna SS, Steffi SR. Antimicrobial Activity of Lysozyme Against Oral Pathogens. Asian Journal of Pharmaceutical Research and Health Care 2016; 8(2): 42 - 6

De Almeida PDV, Grégio AMT, Machado MÂN, de Lima AAS, Azevedo LR. Saliva composition and functions: a comprehensive review. J Contemp Dent Pract 2008 March; 9(3):72-80

Ramos-Casals M, Tzioufas AG, Stone JH, Sisó A, Bosch

X. Treatment of primary Sjögren syndrome: a systematic review. JAMA 2010 Jul 28;304 (4): 452-60

Thomson WM, Lawrence HP, Broadbent JM, Poulton

R. The impact of xerostomia on oral-health-related quality of life among younger adults. Health Qual Life Outcomes 2006; 4: 86

Malouf JG, Aragon C, Henson BS, Eisbruch A, Ship JA. Influence of parotid-sparing radiotherapy on xerostomia in head and neck cancer patients. Cancer Detect Prev 2003; 27(4):305-10

Satishchandra P, Ghezzi EM, Ship JA. Development of a visual analogue scale questionnaire for subjective assessment of salivary dysfunction. Oral Surg Oral Med Oral Pathol Oral Radiol Endodontics. 2001; 91: 311-6

Fox PC, Busch KA, Baum BJ. Subjective reports of xerostomia and objective measures of salivary gland performance. J am Dent Assoc. 1987; 115:581-4

Thomson WM. Issues in the epidemiological investigation of dry mouth. Gerodontology 2005; 22:65-76

Thomson WM, Poulton R, Broadbent JM, Al-Kubaisy

S. Xerostomia and medications among 32-year-olds. Acta Odontologica Scandinavia. 2006; 64: 249–54

Porter SR, Scully C, Hegarty AM. An update of the etiology and management of xerostomia. Oral Surg, Oral Med, Oral Patho, Oral Radio Endodontics 2004;97: 28-46

Locker D. Dental status, xerostomia and the oral health- related quality of life of an elderly institutionalized population. Special Care in Dentistry. 2003;23:86–93

Hopcraft MS, Tan C. Xerostomia: an update for clinicians. Aust dental journal 2010 ; 55:238-44

Greenberg MS, Glick M (Eds). BC Decker Inc. Hamilton Burket's Oral medicine diagnosis and treatment 2003; 10th Edition: 658

Field EA, Fear S, Higham SM, Ireland RS, Rostron J, Willetts RM, et al. Age and medication are significant risk factors for xerostomia in an English population, attending general dental practice. Gerodontology 2001; 18(1): 21-4

Nederfors T, Isaksson R, Mornstad H, Dahlof C. Prevalence of perceived symptoms of dry mouth in an adult Swedish population--relation to age, sex and pharmacotherapy. Community Dent Oral Epidemiol 1997; 25(3):211-6

Davies AN, Broadley K, Beighton D. Salivary gland hypofunction in patients with advanced cancer. Oral Oncol 2002; 38(7): 680-5

Orellana MF, Lagravere MO, Boychuk DG, Major PW, Flores-Mir C. Prevalence of xerostomia in population based samples: a systematic review. J Public Health Dent 2006; 66(2): 152-8

Borges BC, Fulco GM, Souza AJ, de Lima KC. Xerostomia and hyposalivation: a preliminary report of their prevalence and associated factors in Brazilian elderly diabetic patients. Oral Health Prev Dent. 2010; 8(2): 153-8

Salako N, Farsi J. Prevalence of self-reported xerostomia in a cross sectional population in the western province of Saudi Arabia. Saudi Dental Journal 2005; 17(1): 29- 33

Rad M, Kakoie S, Niliye BF, Pourdamghan N. Effect of Long-term Smoking on Whole-mouth Salivary Flow Rate and Oral Health. J Dent Res Dent Clin Dent Prospects 2010; 4(4): 110-4

Russell SL, Reisine S. Investigation of xerostomia in patients with rheumatoid arthritis. J Am Dent Assoc 1998; 129(6): 733-9

Ikebe K, Nokubi T, Sajima H, Kobayashi S, Hata K, Ono T, et al. Perception of dry mouth in a sample of community dwelling older adults in Japan. Spec Care Dentist 2001; 21(2): 52-9

Nederfors T. Xerostomia: prevalence and pharmaco- therapy. With special reference to beta-adrenoreceptor antagonists.Swed Dent J Suppl 1996; 116: 1-7

Thomson WM, Spencer AJ, Salde GD. Medication and dry mouth findings from a cohort study of older people. J public Health Dent 2000; 60(1): 12-20

Downloads

Published

2017-06-05

How to Cite

Shah, S. ., Shah, M. ., Shah, M. ., & Laghari, A. . (2017). Prevalence of Xerostomia in Healthy Individuals. Journal of Bahria University Medical and Dental College, 7(3), 149–151. Retrieved from https://jbumdc.bahria.edu.pk/index.php/ojs/article/view/255

Issue

Section

Original Articles